Unknown

Dataset Information

0

Neuroprotection by endogenous and exogenous PACAP following stroke.


ABSTRACT: We investigated the effects of PACAP treatment, and endogenous PACAP deficiency, on infarct volume, neurological function, and the cerebrocortical transcriptional response in a mouse model of stroke, middle cerebral artery occlusion (MCAO). PACAP-38 administered i.v. or i.c.v. 1 h after MCAO significantly reduced infarct volume, and ameliorated functional motor deficits measured 24 h later in wild-type mice. Infarct volumes and neurological deficits (walking faults) were both greater in PACAP-deficient than in wild-type mice, but treatment with PACAP reduced lesion volume and neurological deficits in PACAP-deficient mice to the same level of improvement as in wild-type mice. A 35,546-clone mouse cDNA microarray was used to investigate cortical transcriptional changes associated with cerebral ischemia in wild-type and PACAP-deficient mice, and with PACAP treatment after MCAO in wild-type mice. 229 known (named) transcripts were increased (228) or decreased (1) in abundance at least 50% following cerebral ischemia in wild-type mice. 49 transcripts were significantly up-regulated only at 1 h post-MCAO (acute response transcripts), 142 were up-regulated only at 24 h post-MCAO (delayed response transcripts) and 37 transcripts were up-regulated at both times (sustained response transcripts). More than half of these are transcripts not previously reported to be altered in ischemia. A larger percentage of genes up-regulated at 24 hr than at 1 hr required endogenous PACAP, suggesting a more prominent role for PACAP in later response to injury than in the initial response. This is consistent with a neuroprotective role for PACAP in late response to injury, i.e., even when administered 1 hr or more after MCAO. Putative injury effector transcripts regulated by PACAP include beta-actin, midline 2, and metallothionein 1. Potential neuroprotective transcripts include several demonstrated to be PACAP-regulated in other contexts. Prominent among these were transcripts encoding the PACAP-regulated gene Ier3, and the neuropeptides enkephalin, substance P (tachykinin 1), and neurotensin.

SUBMITTER: Chen Y 

PROVIDER: S-EPMC4183206 | biostudies-literature | 2006 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Neuroprotection by endogenous and exogenous PACAP following stroke.

Chen Yun Y   Samal Babru B   Hamelink Carol R CR   Xiang Charlie C CC   Chen Yong Y   Chen Mei M   Vaudry David D   Brownstein Michael J MJ   Hallenbeck John M JM   Eiden Lee E LE  

Regulatory peptides 20061004 1-2


We investigated the effects of PACAP treatment, and endogenous PACAP deficiency, on infarct volume, neurological function, and the cerebrocortical transcriptional response in a mouse model of stroke, middle cerebral artery occlusion (MCAO). PACAP-38 administered i.v. or i.c.v. 1 h after MCAO significantly reduced infarct volume, and ameliorated functional motor deficits measured 24 h later in wild-type mice. Infarct volumes and neurological deficits (walking faults) were both greater in PACAP-de  ...[more]

Similar Datasets

| S-EPMC3383680 | biostudies-literature
| S-EPMC3210342 | biostudies-literature
| S-EPMC8689229 | biostudies-literature
| 8689 | ecrin-mdr-crc
| S-EPMC2840276 | biostudies-literature
| S-EPMC3158424 | biostudies-other
| S-EPMC6523261 | biostudies-other
| S-EPMC5260471 | biostudies-literature
| S-EPMC8312641 | biostudies-literature
| S-EPMC6894551 | biostudies-literature